The exon recognition and removal of introns (splicing) from pre-mRNA is a crucial step in the gene expression flow. The process is very complex and therefore susceptible to derangements. Not surprisingly, a significant and still underestimated proportion of disease-causing mutations affects splicing, with those occurring at the 5’ splice site (5’ss) being the most severe ones. This led to the development of a correction approach based on variants of the spliceosomal U1snRNA, which has been proven on splicing mutations in several cellular and mouse models of human disease. Since the alternative splicing mechanisms are strictly related to the sequence context of the exon, we challenged the U1snRNA-mediated strategy in the singular model of th...
Dissection of pleiotropic effects of missense mutations, rarely investigated in inherited diseases, ...
The relationship between the molecular defect, the coagulation and the clinical phenotype in Haemoph...
In a small group of typical hemophilia A (HA) patients no mutations in the F8 coding sequence (cDNA)...
The exon recognition and removal of introns (splicing) from pre-mRNA is a crucial step in the gene e...
Background: In Hemophilia A (HA) patients, splicing mutations account for about 8-10% of all, a s...
Background: Limitations of replacement therapy for coagulation deficiencies encourage research towa...
Mutations affecting specific splicing regulatory elements offer suitable models to better understand...
The ability of variants of the spliceosomal U1snRNA to rescue splicing has been proven in several hu...
A significant proportion of disease-causing mutations affect precursor-mRNA splicing, inducing skipp...
The pathogenic significance of nucleotide variants commonly relies on nucleotide position within the...
In cellular models we have demonstrated that a unique U1snRNA targeting an intronic region downstrea...
Over 30% of human diseases is caused by aberrant mRNA splicing and, among splicing mutations, those...
Background: haemophilia A (HA) is characterized by partial or total deficiency of factor VIII (FVIII...
Broad objectives and specific aims To develop a correction strategy based on Exon Specific U1snRNAs...
Background: Aberrant splicing is a frequent but still underestimated pathogenic mechanism. We studi...
Dissection of pleiotropic effects of missense mutations, rarely investigated in inherited diseases, ...
The relationship between the molecular defect, the coagulation and the clinical phenotype in Haemoph...
In a small group of typical hemophilia A (HA) patients no mutations in the F8 coding sequence (cDNA)...
The exon recognition and removal of introns (splicing) from pre-mRNA is a crucial step in the gene e...
Background: In Hemophilia A (HA) patients, splicing mutations account for about 8-10% of all, a s...
Background: Limitations of replacement therapy for coagulation deficiencies encourage research towa...
Mutations affecting specific splicing regulatory elements offer suitable models to better understand...
The ability of variants of the spliceosomal U1snRNA to rescue splicing has been proven in several hu...
A significant proportion of disease-causing mutations affect precursor-mRNA splicing, inducing skipp...
The pathogenic significance of nucleotide variants commonly relies on nucleotide position within the...
In cellular models we have demonstrated that a unique U1snRNA targeting an intronic region downstrea...
Over 30% of human diseases is caused by aberrant mRNA splicing and, among splicing mutations, those...
Background: haemophilia A (HA) is characterized by partial or total deficiency of factor VIII (FVIII...
Broad objectives and specific aims To develop a correction strategy based on Exon Specific U1snRNAs...
Background: Aberrant splicing is a frequent but still underestimated pathogenic mechanism. We studi...
Dissection of pleiotropic effects of missense mutations, rarely investigated in inherited diseases, ...
The relationship between the molecular defect, the coagulation and the clinical phenotype in Haemoph...
In a small group of typical hemophilia A (HA) patients no mutations in the F8 coding sequence (cDNA)...